PPSG
TMO icon

Princeton Portfolio Strategies Group’s Thermo Fisher Scientific TMO Stock Holding History

Princeton Portfolio Strategies Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$17.4M Sell
34,536
-333
-1% -$157K 3.37% 4
2021
Q1 		$15.9M Sell
34,869
-678
-2% -$324K 3.08% 4
2020
Q4 		$16.6M Buy
35,547
+107
+0.3% +$50.2K 3.27% 4
2020
Q3 		$15.6M Sell
35,440
-702
-2% -$290K 3.42% 5
2020
Q2 		$13.1M Buy
36,142
+32
+0.1% +$10.7K 3.13% 5
2020
Q1 		$10.2M Sell
36,110
-415
-1% -$131K 2.97% 5
2019
Q4 		$11.9M Buy
36,525
+1,219
+3% +$370K 2.79% 7
2019
Q3 		$10.3M Sell
35,306
-210
-0.6% -$60.1K 2.57% 8
2019
Q2 		$10.4M Sell
35,516
-153
-0.4% -$42.1K 2.65% 9
2019
Q1 		$9.76M Sell
35,669
-448
-1% -$111K 2.61% 9
2018
Q4 		$8.08M Sell
36,117
-1,092
-3% -$256K 2.52% 9
2018
Q3 		$9.08M Buy
37,209
+1,289
+4% +$297K 2.36% 10
2018
Q2 		$7.44M Buy
35,920
+581
+2% +$123K 2.16% 11
2018
Q1 		$7.3M Buy
35,339
+177
+0.5% +$37.2K 2.07% 12
2017
Q4 		$6.68M Sell
35,162
-1,431
-4% -$274K 1.82% 14
2017
Q3 		$6.92M Sell
36,593
-986
-3% -$179K 1.87% 10
2017
Q2 		$6.56M Buy
37,579
+744
+2% +$125K 1.88% 13
2017
Q1 		$5.66M Buy
36,835
+575
+2% +$87.9K 1.68% 17
2016
Q4 		$5.12M Buy
36,260
+50
+0.1% +$7.37K 1.61% 20
2016
Q3 		$5.76M Sell
36,210
-425
-1% -$65.5K 1.81% 15
2016
Q2 		$5.41M Buy
36,635
+175
+0.5% +$25.8K 1.75% 19
2016
Q1 		$5.16M Sell
36,460
-411
-1% -$55.1K 1.75% 20
2015
Q4 		$5.23M Buy
36,871
+2,690
+8% +$359K 1.86% 15
2015
Q3 		$4.18M Sell
34,181
-86
-0.3% -$11.2K 1.7% 21
2015
Q2 		$4.45M Buy
34,267
+1,400
+4% +$183K 1.56% 22
2015
Q1 		$4.42M Buy
32,867
+4,465
+16% +$576K 1.7% 20
2014
Q4 		$3.56M Buy
28,402
+1,180
+4% +$143K 1.41% 25
2014
Q3 		$3.31M Buy
27,222
+3,343
+14% +$406K 1.39% 25
2014
Q2 		$2.82M Buy
23,879
+21,029
+738% +$2.47M 1.21% 26
2014
Q1 		$343K Buy
2,850
+300
+12% +$35.7K 0.23% 91
2013
Q4 		$284K Buy
+2,550
New +$254K 0.19% 97

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Princeton Portfolio Strategies Group's TMO Position: Q2 2021 in Review

Princeton Portfolio Strategies Group reduced its Thermo Fisher Scientific (TMO) stake by 0.96% in Q2 2021, selling an estimated $157K and leaving 34,536 shares worth $17.4M. The position accounts for 3.37% of the portfolio, ranked #4.

Princeton Portfolio Strategies Group first reported a position in TMO in Q4 2013 and has held it in 31 quarters since. 2,075 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • Princeton Portfolio Strategies Group held 34,536 shares of Thermo Fisher Scientific worth $17.4M as of Q2 2021.
  • Princeton Portfolio Strategies Group sold 333 Thermo Fisher Scientific shares in Q2 2021, an estimated $157K.
  • Thermo Fisher Scientific made up 3.37% of Princeton Portfolio Strategies Group's portfolio in Q2 2021, its #4 holding.
  • Princeton Portfolio Strategies Group first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 31 quarters since.
  • 2,075 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on Princeton Portfolio Strategies Group's 13F filing for Q2 2021, filed 2 Aug 2021.